- Home
- EXAS vs AVAV Comparison
EXAS vs AVAV Comparison
Compare EXAS & AVAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXAS
- AVAV
- Stock Information
- Founded
- EXAS 1995
- AVAV 1971
- Country
- EXAS United States
- AVAV United States
- Employees
- EXAS N/A
- AVAV N/A
- Industry
- EXAS Medical Specialities
- AVAV Aerospace
- Sector
- EXAS Health Care
- AVAV Industrials
- Exchange
- EXAS Nasdaq
- AVAV Nasdaq
- Market Cap
- EXAS 9.1B
- AVAV 7.4B
- IPO Year
- EXAS N/A
- AVAV 2007
- Fundamental
- Price
- EXAS $45.60
- AVAV $246.65
- Analyst Decision
- EXAS Strong Buy
- AVAV Strong Buy
- Analyst Count
- EXAS 22
- AVAV 12
- Target Price
- EXAS $66.43
- AVAV $281.17
- AVG Volume (30 Days)
- EXAS 3.9M
- AVAV 883.7K
- Earning Date
- EXAS 08-06-2025
- AVAV 09-03-2025
- Dividend Yield
- EXAS N/A
- AVAV N/A
- EPS Growth
- EXAS N/A
- AVAV N/A
- EPS
- EXAS N/A
- AVAV 1.55
- Revenue
- EXAS $2,939,949,000.00
- AVAV $820,627,000.00
- Revenue This Year
- EXAS $14.61
- AVAV $149.20
- Revenue Next Year
- EXAS $12.71
- AVAV $15.45
- P/E Ratio
- EXAS N/A
- AVAV $159.13
- Revenue Growth
- EXAS 12.55
- AVAV 14.50
- 52 Week Low
- EXAS $38.81
- AVAV $102.25
- 52 Week High
- EXAS $72.83
- AVAV $295.90
- Technical
- Relative Strength Index (RSI)
- EXAS 44.47
- AVAV 44.82
- Support Level
- EXAS $40.55
- AVAV $239.15
- Resistance Level
- EXAS $45.45
- AVAV $257.00
- Average True Range (ATR)
- EXAS 2.04
- AVAV 10.54
- MACD
- EXAS 0.07
- AVAV -3.92
- Stochastic Oscillator
- EXAS 63.10
- AVAV 20.08
About EXAS Exact Sciences Corporation
Exact Sciences, headquartered in Madison, Wisconsin, provides cancer screening and diagnostic test products in the United States and internationally. Exact's Cologuard screening test is a noninvasive stool-based DNA test for colorectal cancer. The company also competes in the precision oncology market with Oncotype DX, a suite of tissue-based genomic tests for estimating recurrence risk and likelihood of benefit from chemotherapy for breast and colon cancer, and OncoExTra, a liquid-based comprehensive genomic profiling test. It is also developing liquid biopsy tests for molecular residual disease, colorectal cancer screening, and multicancer screening.
About AVAV AeroVironment Inc.
AeroVironment Inc operates under a single business segment in which it supplies unmanned aircraft systems, tactical missile systems, high-altitude pseudo-satellites, and other related services to government agencies within the United States Department of Defense as well as the United States allied international governments. The systems can help with security, surveillance, or sensing, and provide eyes in the sky without needing an actual person, or driver in the sky.